Imidazoquinoline compounds with an aryloxy or arylalkyleneoxy or hydroxy substituent at the 6, 7, 8, or 9-position, pharmaceutical compositions containing the compounds, intermediates, and methods of use of these compounds as immunomodulators, for modulating cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed. 3M Center, P O Box 33427, Saint Paul, Minnesota 55133-3427 U.S.A. 3M INNOVATIVE PROPERTIES COMPANY 651/CHENP/2006 A 651/CHENP/2006 INDIA 2009-03-20T08:07:47Z 2007-06-22 2006-02-22 303627 2004-08-27 PCT/US2004/028021 A61K 31/4745 WO 2005/020999 MARTIN, Hugues, LINDSTROM, Kyle J.,, MERRILL, Bryon A.,, RICE, Michael J.,, WURST, Joshua R.,, HARALDSON, Chad A.,, KSHIRSAGAR, Tushar ,, HEPPNER, Philip D.,, NIWAS, Shri,, GRIESGRABER, George W.,, RADMER, Matthew R., 20520 0 753 U.S.A. 2003-08-27 60/498,270 2007-06-22 0 232PV8Dx 2009-04-30T18:38:04Z 70110 MARTIN, HUGUES, LINDSTROM, KYLE J.,, MERRILL, BRYON A.,, RICE, MICHAEL J.,, WURST, JOSHUA R.,, HARALDSON, CHAD A.,, KSHIRSAGAR, TUSHAR ,, HEPPNER, PHILIP D.,, NIWAS, SHRI,, GRIESGRABER, GEORGE W.,, RADMER, MATTHEW R 448 3M INNOVATIVE PROPERTIES COMPANY